GB9726575D0 - Nucleic acid, polypeptides, assays, therapeutic methods and means - Google Patents

Nucleic acid, polypeptides, assays, therapeutic methods and means

Info

Publication number
GB9726575D0
GB9726575D0 GBGB9726575.5A GB9726575A GB9726575D0 GB 9726575 D0 GB9726575 D0 GB 9726575D0 GB 9726575 A GB9726575 A GB 9726575A GB 9726575 D0 GB9726575 D0 GB 9726575D0
Authority
GB
United Kingdom
Prior art keywords
polypeptides
assays
nucleic acid
therapeutic methods
therapeutic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9726575.5A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cancer Research Campaign Technology Ltd
Original Assignee
Cancer Research Campaign Technology Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cancer Research Campaign Technology Ltd filed Critical Cancer Research Campaign Technology Ltd
Priority to GBGB9726575.5A priority Critical patent/GB9726575D0/en
Publication of GB9726575D0 publication Critical patent/GB9726575D0/en
Priority to EP98960037A priority patent/EP1037978A1/en
Priority to AU15721/99A priority patent/AU1572199A/en
Priority to CA002313391A priority patent/CA2313391A1/en
Priority to JP2000539134A priority patent/JP2002508180A/en
Priority to GB9827704A priority patent/GB2333776B/en
Priority to PCT/GB1998/003782 priority patent/WO1999031234A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
GBGB9726575.5A 1997-12-16 1997-12-16 Nucleic acid, polypeptides, assays, therapeutic methods and means Ceased GB9726575D0 (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
GBGB9726575.5A GB9726575D0 (en) 1997-12-16 1997-12-16 Nucleic acid, polypeptides, assays, therapeutic methods and means
EP98960037A EP1037978A1 (en) 1997-12-16 1998-12-16 Human rad1 nucleic acid, polypeptides, assays, therapeutic methods and means
AU15721/99A AU1572199A (en) 1997-12-16 1998-12-16 Human RADl nucleic acid, polypeptides, assays, therapeutic methods and means
CA002313391A CA2313391A1 (en) 1997-12-16 1998-12-16 Human rad1 nucleic acid, polypeptides, assays, therapeutic methods and means
JP2000539134A JP2002508180A (en) 1997-12-16 1998-12-16 Human RAD1 nucleic acids, polypeptides, assays, therapeutic methods and means
GB9827704A GB2333776B (en) 1997-12-16 1998-12-16 Human rad1 nucleic acid,polypeptides,assays,therapeutic methods and means
PCT/GB1998/003782 WO1999031234A1 (en) 1997-12-16 1998-12-16 Human rad1 nucleic acid, polypeptides, assays, therapeutic methods and means

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9726575.5A GB9726575D0 (en) 1997-12-16 1997-12-16 Nucleic acid, polypeptides, assays, therapeutic methods and means

Publications (1)

Publication Number Publication Date
GB9726575D0 true GB9726575D0 (en) 1998-02-11

Family

ID=10823699

Family Applications (2)

Application Number Title Priority Date Filing Date
GBGB9726575.5A Ceased GB9726575D0 (en) 1997-12-16 1997-12-16 Nucleic acid, polypeptides, assays, therapeutic methods and means
GB9827704A Expired - Fee Related GB2333776B (en) 1997-12-16 1998-12-16 Human rad1 nucleic acid,polypeptides,assays,therapeutic methods and means

Family Applications After (1)

Application Number Title Priority Date Filing Date
GB9827704A Expired - Fee Related GB2333776B (en) 1997-12-16 1998-12-16 Human rad1 nucleic acid,polypeptides,assays,therapeutic methods and means

Country Status (6)

Country Link
EP (1) EP1037978A1 (en)
JP (1) JP2002508180A (en)
AU (1) AU1572199A (en)
CA (1) CA2313391A1 (en)
GB (2) GB9726575D0 (en)
WO (1) WO1999031234A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3117999A (en) * 1998-03-27 1999-10-18 Icos Corporation Human rad1 cell cycle checkpoint
US6387658B1 (en) * 1999-09-23 2002-05-14 Rigel Pharmaceuticals, Inc. PCNA-associated cell cycle proteins, compositions and methods of use

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5723996A (en) * 1996-05-03 1997-11-26 Erasmus University Human rad

Also Published As

Publication number Publication date
AU1572199A (en) 1999-07-05
CA2313391A1 (en) 1999-06-24
JP2002508180A (en) 2002-03-19
GB2333776A (en) 1999-08-04
GB9827704D0 (en) 1999-02-10
GB2333776B (en) 2000-05-24
EP1037978A1 (en) 2000-09-27
WO1999031234A1 (en) 1999-06-24

Similar Documents

Publication Publication Date Title
GB9710807D0 (en) Nucleic acid binding proteins
IL136696A0 (en) Sigirr dna and polypeptides
EP1001964A4 (en) Tango-78, tango-79, and tango-81 nucleic acid molecules and polypeptides
GB9707980D0 (en) Characterising DNA
AU6458400A (en) Nucleic acid, polypeptides, assays, therapeutic methods and means
EP1186615A4 (en) Novel protein and dna thereof
GB9714971D0 (en) Assays,therapeutic methods and means
EP1018551A4 (en) Megsin protein
EP1239039A4 (en) Novel polypeptide and dna thereof
GB9701710D0 (en) Mammalian protein
IL136695A0 (en) V201 dna and polypeptides
IL136988A0 (en) Novel nucleic acid and polypeptide
IL137493A0 (en) Svph3-13 and spvh3-17 dna and polypeptides
HUP0201660A2 (en) Novel polypeptide and dna thereof
GB9726575D0 (en) Nucleic acid, polypeptides, assays, therapeutic methods and means
GB9704162D0 (en) Assay methods and means
EP1012160A4 (en) Tango-72 and tango-77 nucleic acid molecules and polypeptides
IL179339A0 (en) Svphi-26 nucleic acids, polypeptides and methods for producing the same
EP1142999A4 (en) Novel protein and dna thereof
EP1033402A4 (en) p16-BINDING PROTEINS, GENE THEREOF, AND ANTIBODY THEREAGAINST
IL136693A0 (en) V196 dna and polypeptides
AU2059500A (en) Huhdgfh nucleic acids, polypeptides, methods and uses thereof
EP1111047A4 (en) Novel protein and dna thereof
EP1026245A4 (en) Antigen protein and nucleic acid coding for said protein
GB0120368D0 (en) Assays therapeutic methods and means

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)